29.05.2020, 09:05
Arca Biopharma Nearly Quintuples On Plans To Test A Coronavirus Drug
...
On the stock market today, Arca stock rocketed 386.3% to 19.21. Shares had ended trading Wednesday at 3.95.
Arca said it will study an experimental drug called AB201 in patients with Covid-19 and abnormal blood clotting. Abnormal blood clotting is one of the serious complications of Covid-19. Arca has already tested AB201 in more than 700 patients with other conditions.
...
https://www.investors.com/news/technolog...rug-plans/
![[Bild: ABIOc1dl0304.png]](https://finviz.com/publish/052920/ABIOc1dl0304.png)
...
On the stock market today, Arca stock rocketed 386.3% to 19.21. Shares had ended trading Wednesday at 3.95.
Arca said it will study an experimental drug called AB201 in patients with Covid-19 and abnormal blood clotting. Abnormal blood clotting is one of the serious complications of Covid-19. Arca has already tested AB201 in more than 700 patients with other conditions.
...
https://www.investors.com/news/technolog...rug-plans/